Editorial, J Clin Exp Oncol Vol: 1 Issue: 2
The Pap Test: Is it Time to Move on?
|Vita Salute San Raffaele University School of Medicine, Milano, Italy|
|Corresponding author : Massimo Origoni, MD
Department of Gynecology & Obstetrics, Vita Salute San Raffaele University School of Medicine, Via Olgettina 60, 20132 Milano, Italy
Tel: +39.02.2643.2653; Fax: +39.02.2643.2759
E-mail: [email protected]
|Received: November 03, 2012 Accepted: November 03, 2012 Published: November 07, 2012|
|Citation: Massimo Origoni (2012) The Pap Test: Is it Time to Move on?. Clin Exp Oncol 1:2. doi:10.4172/2324-9110.1000e1046|
The Papanicolaou vaginal smear – the Pap test – for the early detection of cervical cancer in women, represents one of the milestones of the modern medicine and the turning point towards the applicative concepts of preventive oncology. During the 20th century, cytological screening for cervical cancer has been the gold standard and is now widely recognized to have represented one of the major public health advances.